Drug Pricing Center
![pills-943764_1920[1]](https://eadn-wc03-6094147.nxedge.io/wp-content/uploads/2015/01/pills-943764_19201-1500x430.jpg)
Resources
Five Years of State Action to Lower Drug Prices: 2017-2021, May 2021
Pharmacy Cost Work Group MembersEd Achuck, Pharmacy Section Chief, California Department of General Services
Susan Barrett, Executive Director, Green Mountain Care Board, Vermont
Burl Beasley, Director, Pharmacy Services, Oklahoma Office of Management and Enterprise Services
Terry Cothran, Senior Pharmacy Director, Oklahoma Health Care Authority
James DeBenedetti, Director of Plan Management, Covered California
Richard Gottfried, State Assemblyman and Chair of Committee on Health, New York State Assembly, District 75
Kaha Hizanishvili, Chief, Provider and Pharmacy Programs, MassHealth, Massachussetts Executive Office of Health and Human Services
Sonya Jaquez Lewis, State Senator, Colorado State Senate, District 17
Eileen Mallow, Director, Office of Strategic Health Policy, Wisconsin Department of Employee Trust Funds
Kevin Martin, Pharmacy Rates Analyst, Colorado Department of Health Care Policy and Financing
Sara Sadownik, Deputy Director, Research and Cost Trends, Massachusetts Health Policy Commission
David Seltz, Executive Director, Massachusetts Health Policy Commission
Tricia Sieg, Pharmacy Benefit Program Manager, Wisconsin Department of Employee Trust Funds
Donna Sullivan, Chief Pharmacy Officer, Washington State Health Care Authority
Norman Thurston, State Representative, Utah House of Representatives, District 64
Joshua Wojcik, Assistant Comptroller, Connecticut Office of the Comptroller
Andrew York, Executive Director, Maryland Prescription Drug Affordability Board
To learn more about the Center or to receive state-only materials contact Jennifer Reck (jreck@oldsite.nashp.org)
Sign Up for Our Weekly Newsletter
Sign Up for Our Weekly Newsletter
Washington, DC Office:
1233 20th St., N.W., Suite 303Washington, DC 20036
p: (202) 903-0101
f: (202) 903-2790
Contact Us
Phone: 202-903-0101

For individuals living with complex, often chronic conditions, and their families, palliative care can provide relief from symptoms, improve satisfaction and outcomes, and help address critical mental and spiritual needs during difficult times. Now more than ever, there is growing recognition of the importance of palliative care services for individuals with serious illness, such as advance care planning, pain and symptom management, care coordination, and team-based, multi-disciplinary support. These services can help patients and families cope with the symptoms and stressors of disease, better anticipate and avoid crises, and reduce unnecessary and/or unwanted care. While this model is grounded in evidence that demonstrates improved quality of life, better outcomes, and reduced cost for patients, only a fraction of individuals who could benefit from palliative care receive it. 
























































































































































Q&A: A Model Act to Allow Buy-In into a State Purchasing Pool for Prescription Drugs
/in Policy Blogs, Featured News Home Administrative Actions, Model Legislation, Prescription Drug Pricing, State Employee Health Plans, State Rx Legislative Action /by NASHP StaffWhy is creating a state purchasing pool for prescription drugs a good strategy for states? State purchasing pools for prescription drugs leverage public buying power to reduce drug costs. Today, every state purchases prescription drugs for its employees through its state employee health benefit plan. States are among the largest employers in the state and […]
New NASHP Model Legislation Allows Buy-in into State Rx Purchasing Pools for Individuals and Businesses
/in Policy Blogs, Featured News Home Administrative Actions, Model Legislation, Prescription Drug Pricing, State Rx Legislative Action /by Trish Riley and Jennifer ReckStates have considerable prescription drug purchasing power through their state employee health plans and other public purchasers. The National Academy for State Health Policy’s (NASHP) newest legislative model, State Purchasing Pool Buy-in, leverages this purchasing clout by creating a program that allows individuals and businesses to buy into the state’s drug benefit plan to lower […]
Model Pharmacy Benefit Manager Contract Terms Help States Achieve Prescription Drug Savings
/in Policy Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Model Legislation, Prescription Drug Pricing, State Employee Health Plans, State Rx Legislative Action /by Jennifer ReckEighteen Blue Cross Blue Shield Plans Join Civica Rx to Lower Generic Drug Costs
/in Policy California Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Prescription Drug Pricing, State Rx Legislative Action /by Trish RileyTwo weeks after California’s governor announced plans to produce generic drugs, 18 national Blue Cross Blue Shield plans said they will join with the non-profit Civica Rx to produce lower-cost generic drugs. As summarized in the National Academy for State Health Policy’s Jan. 13, 2020, blog Can States Really Produce Generic Drugs? The Civica Rx […]
Legislator Q&A: Colorado Enacts Nation’s First Insulin Cost Cap, Requires Attorney General to Investigate Prices
/in Policy Colorado Blogs, Featured News Home Chronic Disease Prevention and Management, Cost, Payment, and Delivery Reform, Health System Costs, Newly-Enacted Laws, Population Health, Prescription Drug Pricing, State Rx Legislative Action /by Sarah LanfordWebinar: New Tools to Lower Rx Drug Costs – State Buy-In Model Legislation and Model PBM Contract Language, for States Only
/in Policy Webinars Prescription Drug Pricing /by NASHP StaffCan States Really Produce Generic Drugs? The Civica Rx Model May Show the Way
/in Policy California Blogs, Featured News Home Administrative Actions, Cost, Payment, and Delivery Reform, Health System Costs, Prescription Drug Pricing, State Rx Legislative Action /by Trish RileyLast week, Gov. Gavin Newsom captured national attention when he announced California’s intention to produce its own generic drugs, building on earlier state efforts. Last year, the governor issued an executive order charging public payers to combine their purchasing power to negotiate better prices, and to eventually expand to include other payers in the state. […]
NASHP’s Top Five Reads of 2019
/in Policy Blogs, Featured News Home Administrative Actions, Chronic and Complex Populations, Chronic Disease Prevention and Management, Community Health Workers, Health Coverage and Access, Health System Costs, Legislative Tracker, Population Health, Prescription Drug Pricing, State Rx Legislative Action, Work Requirements, Workforce Capacity /by NASHP StaffEach year, NASHP publishes more than 100 reports and resources to give state leaders the information they need to craft effective legislation and health policies. Below are our most-read resources of 2019. Rx Legislative Tracker: This resource with its map interface gives you the status of every state’s legislation to curb prescription drug costs since 2015, […]
Slideshow: State Actions to Address Rising Prescription Drug Costs
/in Policy Featured News Home Administrative Actions, Model Legislation, Newly-Enacted Laws, Prescription Drug Pricing, State Rx Legislative Action /by NASHP StaffSince 2017, the National Academy for State Health Policy has worked with states to develop and implement effective model policies to lower prescription drug prices. This slideshow highlights states’ administrative and legislative actions, including Medicaid innovations and more than 120 new laws that promote pharmacy benefit manager regulation, drug price transparency, wholesale drug importation from […]
Slideshow: State Actions to Address Rising Prescription Drug Costs
/in Policy Reports Administrative Actions, Model Legislation, Newly-Enacted Laws, Prescription Drug Pricing, State Rx Legislative Action /by NASHP StaffSince 2017, NASHP has worked with states to develop and implement effective model policies to lower prescription drug prices. This slideshow highlights states’ administrative and legislative action, including Medicaid innovations and more than 120 new laws that promote pharmacy benefit manager regulation, drug price transparency, wholesale drug importation from Canada, and drug affordability review.